A detailed history of Retirement Income Solutions, Inc transactions in Amgen Inc stock. As of the latest transaction made, Retirement Income Solutions, Inc holds 1,571 shares of AMGN stock, worth $462,706. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,571
Previous 1,571 -0.0%
Holding current value
$462,706
Previous $490,000 3.27%
% of portfolio
0.12%
Previous 0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

SELL
$218.65 - $271.46 $32,797 - $40,719
-150 Reduced 8.72%
1,571 $422,000
Q2 2023

Jul 28, 2023

BUY
$214.27 - $253.37 $32,140 - $38,005
150 Added 9.55%
1,721 $382,000
Q1 2023

May 05, 2023

SELL
$225.79 - $275.2 $8,354 - $10,182
-37 Reduced 2.3%
1,571 $379,000
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $43,515 - $55,291
-190 Reduced 10.57%
1,608 $422,000
Q2 2022

Aug 16, 2022

SELL
$230.71 - $256.74 $922 - $1,026
-4 Reduced 0.22%
1,798 $437,000
Q1 2022

May 06, 2022

BUY
$219.27 - $242.57 $877 - $970
4 Added 0.22%
1,802 $436 Million
Q2 2020

Aug 06, 2020

BUY
$197.81 - $242.74 $11,077 - $13,593
56 Added 3.21%
1,798 $424 Million
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $12,756 - $16,919
-70 Reduced 3.86%
1,742 $353 Million
Q2 2019

Jul 23, 2019

SELL
$166.7 - $195.41 $33,340 - $39,082
-200 Reduced 9.94%
1,812 $334 Million
Q4 2018

Jan 30, 2019

SELL
$178.4 - $208.25 $19,267 - $22,491
-108 Reduced 5.09%
2,012 $392 Million
Q3 2018

Nov 01, 2018

SELL
$185.29 - $208.89 $9,079 - $10,235
-49 Reduced 2.26%
2,120 $439 Million
Q2 2018

Jul 26, 2018

BUY
$166.05 - $186.51 $9,464 - $10,631
57 Added 2.7%
2,169 $400 Million
Q1 2018

Apr 30, 2018

SELL
$169.43 - $198.0 $256,855 - $300,168
-1,516 Reduced 41.79%
2,112 $360 Million
Q4 2017

Feb 06, 2018

BUY
$168.79 - $188.59 $612,370 - $684,204
3,628
3,628 $631 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Retirement Income Solutions, Inc Portfolio

Follow Retirement Income Solutions, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Income Solutions, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Income Solutions, Inc with notifications on news.